Unimolecular polypharmacy for treatment of diabetes and obesity
Standard cagrilintide dosing follows a 12-week titration from 0.6mg to 2.4mg weekly (0.6mg weeks 1-4, 1.2mg weeks 5-8, 1.8mg weeks 9-12, 2.4mg week 13+)
D.ZhaoR.ChenJ.ShenY.MooreR
Anticoagulation lowers the risk of ischemic stroke but may increase the risk of recurrent ICH
Interstitial Cystitis/Bladder Pain Syndrome is defined as An unpleasant sensation (pain, pressure, discomfort) perceived to be related to the urinary bladder, associated with lower urinary tract symptoms of more than six weeks duration, in the absence of infection or other identifiable causes. An unpleasant sensation (pain, pressure, discomfort) perceived to be related to the urinary bladder, associated with lower urinary tract symptoms of more than six weeks duration, in the absence of infection or other identifiable causes. Over the years, this diagnosis has changed dramatically from how it is defined to approaching treatment
That defined formula helps patients understand what is included before scheduling
